期刊论文详细信息
| Frontiers in Oncology | |
| Measurable Residual Disease-Guided Treatment to Prevent Relapse in Acute Myeloid Leukemia and Myelodysplastic Syndrome | |
| 关键词: acute myeloid leukemia; myelodysplastic syndrome; measurable residual disease; hypomethylating agents; azacitidine; stem-cell transplant; | |
| DOI : 10.3389/fonc.2020.576924 | |
| 来源: DOAJ | |
【 授权许可】
Unknown